Kicking Ass, Taking Names.

28 06 2005

In the past 24 hours the stock price of Cubist shares has been up 25% due to the fact that our Phase III trials of Cubicin in the treatment of endocarditis and bacteremia were positive, and we will be filing an sNDA with the FDA for approval to use it in these indications. It means lots more sales of our already well-selling flagship drug. Ooo-rah. Go Cubist.Growth Around the Corner? (Motley Fool)

Comment : 1 Comment »
Categories : The Man
Trackbacks : No Trackbacks »

Trackbacks

Trackback specific URI for this entry

No Trackbacks

Comments

Display comments as (Linear | Threaded)

30 06 2005: #1 Ryan (Reply)

If I had any clue what any of that meant, I'd applaud you.

But since I dont, No applause for you.
Comment (1)

Add Comment

Name

Homepage

In reply to

Comment

Enclosing asterisks marks text as bold (*word*), underscore are made via _word_.

Standard emoticons like :-) and ;-) are converted to images.

To prevent automated Bots from commentspamming, please enter the string you see in the image below in the appropriate input box. Your comment will only be submitted if the strings match. Please ensure that your browser supports and accepts cookies, or your comment cannot be verified correctly.
CAPTCHA